140 related articles for article (PubMed ID: 284810)
1. Terminal erythroid differentiation in normal and leukemic mouse cells.
Eisen H
Blood Cells; 1978; 4(1-2):177-88. PubMed ID: 284810
[TBL] [Abstract][Full Text] [Related]
2. Regulation of differentiation in transformed erythroid cells.
Rifkind RA; Marks PA
Blood Cells; 1978; 4(1-2):189-206. PubMed ID: 371697
[TBL] [Abstract][Full Text] [Related]
3. Cytochemical characteristics of leukopoietic differentiation in murine erythroleukemic (Friend) cells.
Fioritoni G; Bertolini L; Torlontano G; Revoltella R
Cancer Res; 1980 Mar; 40(3):866-72. PubMed ID: 6937242
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
Tsiftsoglou AS; Wong W
Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045
[TBL] [Abstract][Full Text] [Related]
5. The role of erythropoietin in the production of principal erythrocyte proteins other than hemoglobin during terminal erythroid differentiation.
Koury MJ; Bondurant MC; Mueller TJ
J Cell Physiol; 1986 Feb; 126(2):259-65. PubMed ID: 3080441
[TBL] [Abstract][Full Text] [Related]
6. Role of nonhemoglobin heme accumulation in the terminal differentiation of Friend erythroleukemia cells.
Lo SC; Aft R; Mueller GC
Cancer Res; 1981 Mar; 41(3):864-70. PubMed ID: 6936076
[TBL] [Abstract][Full Text] [Related]
7. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
8. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation.
Kirsch IR; Bertness V; Silver J; Hollis GF
J Cell Biochem; 1986; 32(1):11-21. PubMed ID: 3464612
[TBL] [Abstract][Full Text] [Related]
9. Early and late volume changes during erythroid differentiation of cultured Friend leukemic cells.
Loritz F; Bernstein A; Miller RG
J Cell Physiol; 1977 Mar; 90(3):423-37. PubMed ID: 265944
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells.
Petrak J; Myslivcova D; Man P; Cmejlova J; Cmejla R; Vyoral D
Exp Hematol; 2007 Feb; 35(2):193-202. PubMed ID: 17258068
[TBL] [Abstract][Full Text] [Related]
11. Erythroid differentiation and the cell cycle: some implications from murine foetal and erythroleukemic cells.
Rifkind RA; Marks PA; Bank A; Terada M; Maniatis GM; Reuben R; Fibach E
Ann Immunol (Paris); 1976; 127(6):887-93. PubMed ID: 1070288
[TBL] [Abstract][Full Text] [Related]
12. Dimethyl sulfoxide-induced differentiation of Friend erythroleukemia cells in the absence of cytokinesis.
Tsiftsoglou AS; Sartorelli AC
Cancer Res; 1979 Oct; 39(10):4058-63. PubMed ID: 289437
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanism of erythroid differentiation in mouse Friend cells].
Oishi M
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):623-8. PubMed ID: 6424578
[TBL] [Abstract][Full Text] [Related]
14. Presence of spectrin in untreated Friend erythroleukemic cells. Its accumulation upon treatment of the cells with dimethyl sulfoxide.
Rossi GB; Aducci P; Gambari R; Minetti M; Vernole P
J Cell Physiol; 1978 Dec; 97(3 Pt 1):293-304. PubMed ID: 365872
[TBL] [Abstract][Full Text] [Related]
15. [Commitment to erythroid differentiation and globin gene expression in the absence of heme accumulation in Friend leukemia cells].
Gambari R
Boll Soc Ital Biol Sper; 1983 May; 59(5):631-7. PubMed ID: 6882562
[TBL] [Abstract][Full Text] [Related]
16. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
[TBL] [Abstract][Full Text] [Related]
17. [Molecular basis of erythroid cell differentiation and its implication in clinical medicine (author's transl)].
Terada M
Tanpakushitsu Kakusan Koso; 1974 May; 19(5):379-87. PubMed ID: 4607913
[No Abstract] [Full Text] [Related]
18. Erythropoietin control of terminal erythroid differentiation: maintenance of cell viability, production of hemoglobin, and development of the erythrocyte membrane.
Koury MJ; Bondurant MC; Atkinson JB
Blood Cells; 1987; 13(1-2):217-26. PubMed ID: 3478108
[TBL] [Abstract][Full Text] [Related]
19. Splenic erythroblasts in anemia-inducing Friend disease: a source of cells for studies of erythropoietin-mediated differentiation.
Koury MJ; Sawyer ST; Bondurant MC
J Cell Physiol; 1984 Dec; 121(3):526-32. PubMed ID: 6501430
[TBL] [Abstract][Full Text] [Related]
20. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
